Effects of Whole Grain Rye on Metabolic Risk Markers and Mood

The purpose of the study is to investigate, in healthy middle age subjects, effects of whole grain rye on cognitive functions, mood, and cardiovasculair risk markers

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Metabolic Disorders and Cognitive Decline Cognition Disorders Cognitive Dysfunction Mental Disorders Metabolic Diseases Neurocognitive Disorders Nutritional and Metabolic Diseases

Age range

50 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

healthy
BMI 19-28
plasma glucose < 6.1 mmol/L
non smooker

Exclusion criteria

known metabolic diseases
known gastrointestinal disorders
known cognitive decline.

Treatment and study plan

Whole Grain

Other

whole grain rye

reference

Other

white wheat bread

Primary outcomes

cognitive performance

Time frame: postprandial 0-180 min after breakfast

test of working memory capacity

Secondary outcomes

glucose tolerance

Time frame: 0-180 min after breakfast

postprandial glucose concentrations

Sponsors and collaborators

Lead sponsor

Lund University

Other

Registry information

Official study title

Effects of Whole Grain on Cognitive Performance and Mood, and the Relationships to Cardiometabolic Risk Markers

Important dates

Study start: 2016
Primary completion: 2017
Study completion: 2017
First posted: Sep 8, 2017
Registry last updated: Oct 4, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed